Related Experiment Video
Updated: Aug 25, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Congenital gonadotropin deficiency in boys: management during childhood
L Adan1, A C Couto-Silva, C Trivin
1Université René Descartes and Pediatric Endocrinology Unit, Fondation-Hópital Saint Joseph, Paris, France.
Insights
Low plasma inhibin B and anti-Müllerian hormone (AMH) levels may signal testicular damage in boys with congenital gonadotropin deficiency (CGD). Testosterone treatment effectively restored normal penis length in all patients studied.
Area of Science:
- Pediatric Endocrinology
- Reproductive Medicine
- Developmental Biology
Background:
- Congenital gonadotropin deficiency (CGD) affects pubertal development and reproductive health in boys.
- Assessing testicular function in prepubertal and pubertal boys with CGD is crucial for management.
- Hormonal markers like inhibin B and anti-Müllerian hormone (AMH) may offer insights into testicular function.
Purpose of the Study:
- To characterize boys diagnosed with congenital gonadotropin deficiency (CGD).
- To evaluate the predictive value of plasma inhibin B and AMH for testicular function in these boys.
- To assess the impact of testosterone treatment on physical development.
Main Methods:
- A cohort of 19 boys with CGD, including five with Kallmann syndrome, was prospectively followed.
- Clinical features such as micropenis and delayed puberty were recorded.
- Hormonal levels (inhibin B, AMH, LH, GnRH) and testicular palpation were assessed.
Main Results:
- Boys presented with micropenis (before age 14) or delayed puberty (after age 14).
- Testicular non-palpability was noted in 13 patients.
- Low plasma inhibin B and AMH were observed in some patients, potentially indicating testicular damage, while testosterone treatment normalized penis length.
Conclusions:
- Low plasma inhibin B and AMH concentrations may serve as indicators of testicular damage in boys with CGD.
- Testosterone replacement therapy is effective in achieving normal penile growth in boys with CGD.
Objective:
To analyze the features of boys with congenital gonadotropin deficiency (CGD), and to determine the value of plasma inhibin B and anti-Müllerian hormone (AMH) for predicting testicular function and the effect of testosterone treatment.
Patients:
We followed 19 boys for CGD, including five with Kallmann syndrome.
Results:
The boys were seen before 14 years of age for micropenis (9 boys) or later for delayed puberty (10 boys). No testis was palpable in the scrotum in 13 patients, bilaterally in seven of them. Luteinizing hormone (LH) peak after a gonadotropin releasing hormone (GnRH) test was between 0.5 and 5.6 U/l. Plasma inhibin B was low in the four patients evaluated at less than 1 year old. AMH was low in one of them and normal in four others. Of the older patients, three lad low plasma inhibin B and four had normal concentrations; plasma AMH was low in three of them and increased in four. Testosterone treatment restored penis length to normal in all patients.
Conclusions:
Low plasma inhibin B and AMH concentrations may indicate testicular damage in boys with CGD.
Related Concept Videos
Infertility in Males
Sex-linked Disorders
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
The Y Chromosome Determines Maleness
Evolution
Around 300 million years ago, the two sex chromosomes diverged from two identical autosomal chromosomes. Over time, the Y chromosome has lost most of its genes, shrinking in size. Today,...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
